VeriTeQ licenses its RFID microtransponder system to Establishment Labs for that company's breast implants.
VeriTeQ (OTC:VTEQD) stands to gain more than $10 million from a licensing deal with Establishment Labs, which will use its medical device RFID tech for breast implants.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1J3ZWbB
Cap comentari:
Publica un comentari a l'entrada